Tabula Rasa HealthCare (TRHC) Tops Q2 EPS by 5c, Offers Guidance

Tabula Rasa HealthCare (NASDAQ: TRHC) reported Q2 EPS of $0.20, $0.05 better than the analyst estimate of $0.15. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $46.82 million.

GUIDANCE:

Tabula Rasa HealthCare sees Q3 2018 revenue of $52-53 million, versus the consensus of $49.3 million.

Tabula Rasa HealthCare sees FY2018 revenue of $190-200 million, versus the consensus of $193.4 million.

For earnings history and earnings-related data on Tabula Rasa HealthCare (TRHC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c